These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27911793)

  • 1. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals.
    Ryan PL; Sumaria N; Holland CJ; Bradford CM; Izotova N; Grandjean CL; Jawad AS; Bergmeier LA; Pennington DJ
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14378-14383. PubMed ID: 27911793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic Cells Are Critical for the Activation and Expansion of Vδ2
    Wang X; Liu J; Gao H; Mo XD; Han T; Xu LP; Zhang XH; Huang XJ
    Front Immunol; 2018; 9():2528. PubMed ID: 30443256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells.
    Sacchi A; Tumino N; Sabatini A; Cimini E; Casetti R; Bordoni V; Grassi G; Agrati C
    Front Immunol; 2018; 9():1271. PubMed ID: 29928279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.
    Alejenef A; Pachnio A; Halawi M; Christmas SE; Moss PA; Khan N
    Clin Exp Immunol; 2014 Jun; 176(3):418-28. PubMed ID: 24547915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Frequencies of Circulating IFN-γ-Producing Vδ1(+) and Vδ2(+) γδ T Cells in Patients with Asymptomatic Persistent Hepatitis B Virus Infection.
    Conroy MJ; Mac Nicholas R; Taylor M; O'Dea S; Mulcahy F; Norris S; Doherty DG
    Viral Immunol; 2015 May; 28(4):201-8. PubMed ID: 25789722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
    Negash M; Tsegaye A; Wassie L; Howe R
    BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
    Deniger DC; Maiti SN; Mi T; Switzer KC; Ramachandran V; Hurton LV; Ang S; Olivares S; Rabinovich BA; Huls MH; Lee DA; Bast RC; Champlin RE; Cooper LJ
    Clin Cancer Res; 2014 Nov; 20(22):5708-19. PubMed ID: 24833662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.
    Fisher JP; Yan M; Heuijerjans J; Carter L; Abolhassani A; Frosch J; Wallace R; Flutter B; Capsomidis A; Hubank M; Klein N; Callard R; Gustafsson K; Anderson J
    Clin Cancer Res; 2014 Nov; 20(22):5720-32. PubMed ID: 24893631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ CD25(high) Foxp3+ regulatory T cells downregulate human Vdelta2+ T-lymphocyte function triggered by anti-CD3 or phosphoantigen.
    Mahan CS; Thomas JJ; Boom WH; Rojas RE
    Immunology; 2009 Jul; 127(3):398-407. PubMed ID: 19019089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
    Harly C; Peyrat MA; Netzer S; Déchanet-Merville J; Bonneville M; Scotet E
    Blood; 2011 Mar; 117(10):2864-73. PubMed ID: 21233315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
    Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
    Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells.
    Michishita Y; Hirokawa M; Guo YM; Abe Y; Liu J; Ubukawa K; Fujishima N; Fujishima M; Yoshioka T; Kameoka Y; Saito H; Tagawa H; Takahashi N; Sawada K
    Int J Hematol; 2011 Sep; 94(3):230-240. PubMed ID: 21858446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.
    Rischer M; Pscherer S; Duwe S; Vormoor J; Jürgens H; Rossig C
    Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
    Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
    Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis).
    Fazio J; Quabius ES; Müller A; Adam-Klages S; Wesch D; Sebens S; Kalyan S; Lamprecht P; Kabelitz D
    Clin Immunol; 2013 Oct; 149(1):65-72. PubMed ID: 23891739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
    Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
    Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function.
    Rodin W; Szeponik L; Rangelova T; Tamiru Kebede F; Österlund T; Sundström P; Hogg S; Wettergren Y; Cosma A; Ståhlberg A; Bexe Lindskog E; Quiding Järbrink M
    Cancer Immunol Immunother; 2024 Jul; 73(9):174. PubMed ID: 38953978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive activity of Vδ2
    Schilbach K; Krickeberg N; Kaißer C; Mingram S; Kind J; Siegers GM; Hashimoto H
    Cancer Immunol Immunother; 2020 Apr; 69(4):593-610. PubMed ID: 31982940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
    Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
    J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
    Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
    J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.